Metabolische Azidose bei Urämie

Zusammenfassung

Die metabolische Azidose ist eine häufige Komplikation der chronischen Nierenerkrankung (CKD). Mit voranschreitendem GFR-Verlust sinkt die renale Säuresekretion und die Pufferkapazität der Nieren, was zu einer Instabilität des pH-Wertes und damit zu ernsthaften Folgeerkrankungen führt. Die Stabilisierung des pH-Wertes ist das prioritäre Therapieziel und wird folgend diskutiert.

Publication History

Article published online:
14 April 2025

• Literatur

• 1 Wesson DE, Buysse JM, Bushinsky DA. Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease. J Am Soc Nephrol 2020; 31: 469-482
• 2 Weiner ID, Mitch WE, Sands JM. Urea and Ammonia Metabolism and the Control of Renal Nitrogen Excretion. Clin J Am Soc Nephrol 2015; 10: 1444-1458
• 3 [Anonym]. Chapter 3: Management of progression and complications of CKD. Kidney Int Suppl (2011) 2013; 3: 73-90
• 4 Ikizler TA, Burrowes JD, Byham-Gray LD. et al. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. Am J Kidney Dis 2020; 76: S1-S107
• 5 Loniewski I, Wesson DE. Bicarbonate therapy for prevention of chronic kidney disease progression. Kidney Int 2014; 85: 529-535
• 6 Scialla JJ, Anderson CA. Dietary acid load: a novel nutritional target in chronic kidney disease?. Adv Chronic Kidney Dis 2013; 20: 141-149
• 7 Melamed ML, Raphael KL. Metabolic Acidosis in CKD: A Review of Recent Findings. Kidney Med 2021; 3: 267-277
• 8 Yang TY, Lin HM, Wang HY. et al. Sodium Bicarbonate Treatment and Clinical Outcomes in Chronic Kidney Disease with Metabolic Acidosis: A Meta-Analysis. Clin J Am Soc Nephrol 2024; 19: 959-969
• 9 Raphael KL, Wei G, Baird BC. et al. Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans. Kidney Int 2011; 79: 356-362
• 10 Madias NE. Metabolic Acidosis and CKD Progression. Clin J Am Soc Nephrol 2021; 16: 310-312
• 11 Di Iorio BR, Bellasi A, Raphael KL. et al. Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study. J Nephrol 2019; 32: 989-1001
• 12 Mohebbi N, Ritter A, Wiegand A. et al. Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial. Lancet 2023; 401: 557-567
• 13 Ravi KS, Tumlin JA, Roy-Chaudhury P. et al. Association of Dialysate Bicarbonate with Arrhythmia in the Monitoring in Dialysis Study. Kidney360 2024; 5: 1490-1499
• 14 Serpa Neto A, Nasser A, Marella P. et al. Impact of mild hypercapnia in critically ill patients with metabolic acidosis. J Crit Care 2024; 85: 154936
• 15 Billings FTt, Shaw AD. Clinical trial endpoints in acute kidney injury. Nephron Clin Pract 2014; 127: 89-93
• 16 Svendsen SL, Rousing AQ, Carlsen RK. et al. A Urine pH-Ammonium Acid/Base Score and CKD Progression. J Am Soc Nephrol 2024; 35: 1533-1545
• 17 Marecek R, Kissling S, Teso AD. et al. Chronic metabolic acidosis in a patient with diabetes on maintenance haemodialysis: mind the anion gap. Lancet 2024; 404: 570-571